R&Q's Blog

Medical device industry news and trends - and the resources to understand and act on them.

 

This New Med Device Will Help You Sleep Better

Everyone appreciates a good night's sleep.

A big obstacle to that is the fact that 18 million American adults suffer from Obstructive Sleep Apnea (OSA), and the condition arises simply from a wayward throat muscle. A new study by Dr. Richard Schwab, co-medical director of the Sleep Center at the University of Pennsylvania School of Medicine, shows how a new technique that can correct the issue.

When Benefit Outweighs Risk: Creating a Successful Clinical Evaluation Report - A Case Study

About R&Q's Case Studies: We hope you enjoy our third case study. View all of our available Case Studies. Subscribing to our blog is the best way to know when future case studies are available.

 

Challenge

High volume of data... and differing opinions.

A client's product is utilized on critically ill patients in intensive care units. As a result, comorbidities and adverse events during the use of the device are inevitable. There were more than a thousand customer complaints and hundreds of serious adverse events reported to public databases for the subject device and comparative devices. Notified body findings on the previous clinical evaluation reports and internal conflict over the requirements added to the confusion.

Deep Breaths

The standard treatment for patients with cancer of the larynx is to have a tracheostomy tube installed. Tracheostomy tubes are Class II devices, under 21 CFR 868.5800. According to ProTip CEO Maurice Beranger, this technology has not changed in 140 years. Tracheostomy tubes impair a patient’s ability to breathing through the upper airway and talk normally.

October brings awareness to women’s health issues

October is a very important month for women: It’s National Breast Cancer Awareness Month. There are many things to be proud of for how far we have come with treating breast cancer. The Susan G. Komen Foundation reports that the 5-year survival rate for female breast cancer survivors in the U.S. has improved from 63% in the early 1960’s to 90% today. Thanks to advances in technology and awareness of the disease, we have been able to make great strides.

Lists by Topic

see all